5-Azacitidine Maintenance vs Observation After Transplant in High-Risk AML and MDS Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 3 Randomized Study of 5-Azacitidine Maintenance vs Observation After Transplant in High-Risk AML and MDS Patients
Blood Adv 2020 Nov 10;4(21)5580-5588, B Oran, M de Lima, G Garcia-Manero, PF Thall, R Lin, U Popat, AM Alousi, C Hosing, S Giralt, G Rondon, G Woodworth, RE ChamplinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.